Coenzyme Q10

Encyclopedia of Dietary Supplements

Volumn , Issue , 2004, Pages 121-131

  Dallner, Gustav ^a   Stocker, Roland ^b  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85059714704     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1081/E-EDS-120022077     Document Type: Chapter

References (28)

1. 10 in plasma by a single dilution step. Anal. Biochem. 2002, 305, 49–54.
2. Grünler, J.; Ericsson, J.; Dallner, G.; Branchpoint reactions in the biosynthesis of cholesterol, dolichol, ubiquinone and prenylated proteins. Biochim. Biophys. Acta. 1994, 1212, 259–277.
3. Morré, D.J.; Morré, D.M.; Cell surface NADH oxidases (ECTO-NOX proteins) with roles in cancer, cellular time-keeping, growth, aging and neurodegenerative diseases. Free Radic. Res. 2003, 37, 795–808.
4. Fontaine, E.; Ichas, F.; Bernardi, P.; A ubiquinone- binding site regulates the mitochondrial permeability transition pore. J. Biol. Chem. 1998, 273, 25734–25740.
5. Echtay, K.S.; Winkler, E.; Frischmuth, K.; Klingenberg, M. Uncoupling proteins 2 and 3 are highly active H þ transporters and highly nucleotide sensitive when activated by coenzyme Q (ubiquinone). Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 1416–1421.
6. Stocker, R.; Bowry, V.W.; Frei, B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does a-tocopherol. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 1646–1650.
7. 10 in apolipoprotein E gene knockout mice. Free Radic. Biol. Med. 2000, 29, 295–305.
8. 10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation. Biochim. Biophys. Acta. 1992, 1126, 247–254.
9. 10. Biochem. Biophys. Res. Commun. 2002, 296, 255–260.
10. 10 in isolated systolic hypertension. South Med. J. 2001, 94, 1112–1117.
11. 10 improves endothelial dysfunction of the brachial artery in type II diabetes mellitus. Diabetologia 2002, 45, 420–426.
12. Turunen, M.; Olsson, J.; Dallner, G.; Metabolism and function of coenzyme Q. Biochim. Biophys. Acta. 2004, 1660, 171–199.
13. 10 enrichment decreases oxidative DNA damage in human lymphocytes. Free Radic. Biol. Med. 1999, 27, 1027–1032.
14. 10 increases T4/T8 ratios of lymphocytes in ordinary subjects and relevance to patients having the AIDS related complex. Biochem. Biophys. Res. Commun. 1991, 176, 786–791.
15. 10 in rat. Free Radic. Biol. Med. 2003, 34, 563–575.
16. Rustin, P.; Munnich, A.; Rӧtig, A. Mitochondrial respiratory chain dysfunction caused by coenzyme Q deficiency. Meth. Enzymol. 2004, 382, 81–86.
17. 10: biliary and urinary excretion study in guinea pigs. Biofactors 1999, 9, 111–119.
18. Faust, J.R.; Brown, M.S.; Goldstein, J.L. Synthesis of delta 2-isopentenyl tRNA from mevalonate in cultured human fibroblasts. J. Biol. Chem. 1980, 255, 6546–6548.
19. Lӧw, P.; Andersson, M.; Edlund, C.; Dallner, G. Effects of mevinolin treatment on tissue dolichol and ubiquinone levels in the rat. Biochim. Biophys. Acta. 1992, 1165, 102–109.
20. Aberg, F.; Zhang, Y.; Appelkvist, E.L.; Dallner, G.; Effects of clofibrate, phthalates and probucol on ubiquinone levels. Chem. Biol. Interact. 1994, 91, 1–14.
21. Kalen, A.; Appelkvist, E.L.; Dallner, G. Agerelated changes in the lipid compositions of rat and human tissues. Lipids 1989, 24, 579–584.
22. 10 Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 901–904.
23. 10 in congestive cardiomyopathy. Am. J. Ther. 1997, 4, 66–72.
24. 10 as a possible treatment for neurodegenerative diseases. Free Radic. Res. 2002, 36, 455–460.
25. Lodi, R.; Hart, P.E.; Rajagopalan, B.; Taylor, D.J.; Crilley, J.G.; Bradley, J.L.; Blamire, A.M.; Manners, D.; Styles, P.; Schapira, A.H.V.; Cooper, J.M.; Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich’s ataxia. Ann. Neurol. 2001, 49, 590–596.
26. 10 in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): evaluation by noninvasive tissue oximetry. J. Neurol. Sci. 1999, 162, 65–68.
27. Ghirlanda, G.; Oradei, A.; Manto, A.; Lippa, S.; Uccioli, L.; Greco, A.V.; Littarru, G.P. Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebocontrolled study. J. Clin. Pharmacol. 1993, 33, 226–229.
28. 10 supplementation on tissue Q10 levels and adenine nucleotide catabolism during high-intensity exercise. Int J. Sport Nutr. 1999, 9, 166–180.